Arcus Biosciences (RCUS) Prepaid Assets (2017 - 2026)
Arcus Biosciences (RCUS) posted quarterly Prepaid Assets of $19.0 million for Q1 2026, little changed year-over-year from $19.0 million in Q1 2025, and up 26.67% quarter-over-quarter from $15.0 million in Q4 2025.
Arcus Biosciences (RCUS) Prepaid Assets (2017 - 2026) Analysis & Trends
Arcus Biosciences' Prepaid Assets history runs 10 years deep, the most recent figure standing at $19.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets changed 0.0% year-over-year to $19.0 million; the TTM figure through Mar 2026 stood at $19.0 million (changed 0.0% YoY), while the FY2025 annual figure was $15.0 million, down 16.67% from the prior year.
- Prepaid Assets for Q1 2026 stood at $19.0 million, up from $15.0 million in the prior quarter.
- The five-year high for Prepaid Assets was $34.0 million in Q4 2023, with the low at $15.0 million in Q3 2025.
- The 5-year median for Prepaid Assets is $20.0 million (2025), against an average of $22.0 million.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets surged 113.44% in 2022, then sank 47.06% in 2024.
- Arcus Biosciences' Prepaid Assets stood at $19.0 million in 2022, then surged by 78.95% to $34.0 million in 2023, then tumbled by 47.06% to $18.0 million in 2024, then fell by 16.67% to $15.0 million in 2025, then increased by 26.67% to $19.0 million in 2026.
- Business Quant data shows RCUS's Prepaid Assets at $19.0 million in Q1 2026, $15.0 million in Q4 2025, and $15.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.00 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 15.00 Mn |
| Sep 30, 2025 | 15.00 Mn |
| Jun 30, 2025 | 20.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | 18.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 25.00 Mn |
| Mar 31, 2024 | 34.00 Mn |
| Dec 31, 2023 | 34.00 Mn |
| Sep 30, 2023 | 31.00 Mn |
| Jun 30, 2023 | 22.00 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | 21.63 Mn |
| Jun 30, 2022 | 15.67 Mn |
| Mar 31, 2022 | 18.53 Mn |
| Dec 31, 2021 | 18.00 Mn |
| Sep 30, 2021 | 17.57 Mn |